Companies: 10,795·Total market cap: $144.5T
GB Sciences, Inc.

GB Sciences, Inc.

GBLXOTCHealthcare● Active
$0.00
+$0.00(+33.33%)
Market Cap$162828
P/E Ratio
52W High$0.50015
52W Low$0.0001
Overview

GB Sciences, Inc. (GBLX) Revenue

Annual & quarterly revenue history · segment & region breakdown

GBLX · revenue · updated Jun 9, 2026

Core revenue metrics

GB Sciences, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$0K
2 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · GB Sciences, Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
GBLX revenue by year · GBLX revenue history · GBLX annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income GB Sciences, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

GB Sciences, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from GB Sciences, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

GBLX revenue · 4 questions

GBLX's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

GBLX revenueGBLX annual revenuewhat is GBLX revenueGBLX TTM revenue

Source: FMP · GB Sciences, Inc. SEC filings · GAAP · GB Sciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026